• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀载纳米泡囊在心肌缺血再灌注损伤急性期有效下调 MAPK-NF-κB 通路。

Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury.

机构信息

Department of Cellular and Molecular Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Mol Biol Rep. 2022 Nov;49(11):10377-10385. doi: 10.1007/s11033-022-07891-3. Epub 2022 Sep 12.

DOI:10.1007/s11033-022-07891-3
PMID:36097124
Abstract

BACKGROUND

Simvastatin can potentially mitigate acute inflammatory phase of myocardial ischemia-reperfusion injury. However, these effects negatively influenced by its poor bioavailability, low water solubility and high metabolism. Here, we investigated the effects of SIM-loaded nano-niosomes on a rat model of MI/R injury to find a drug delivery method to tackle the barriers.

METHODS

Nano-niosomes' characteristics were identified using dynamic light scattering and transmission electron microscopy. Fifty male Wistar rats were divided into five groups: Sham; MI/R; MI/R + nano-niosome; MI/R + SIM; MI/R + SIM-loaded nano-niosomes. Left anterior descending artery was ligated for 45 min, and 3 mg/kg SIM, nano-niosomes, or SIM-loaded nano-niosomes was intramyocardially injected ten min before the onset of reperfusion. ELISA assay was used to assess cardiac injury markers (cTnI, CK-MB) and inflammatory cytokines (TNF-α, IL-6, TGF-β, MPC-1). Expression level of MAPK-NF-κB and histopathological changes were evaluated by western blot and hematoxylin & eosin staining, respectively.

RESULTS

the size of nano-niosome was 137 nm, reached to 163 nm when simvastatin was loaded. To achieve optimized niosomes span 80, a drug/cholesterol ratio of 0.4 and seven min of sonication time was applied. Optimized entrapment efficiency of SIM-loaded nano-niosomes was 98.21%. Inflammatory cytokines and the expression level of MAPK and NF-κB were reduced in rats receiving SIM-loaded nano-niosomes compared to MI/R + SIM and MI/R + SIM-loaded nano-niosomes.

CONCLUSION

Our results showed that SIM-loaded nano-niosomes could act more efficiently than SIM in alleviating the acute inflammatory response of reperfusion injury via downregulating the activation of MAPK-NF-κB.

摘要

背景

辛伐他汀可能减轻心肌缺血再灌注损伤的急性炎症期。然而,其生物利用度差、水溶性低和代谢率高,这些影响使其效果不佳。在此,我们研究了 SIM 载纳米囊泡对 MI/R 损伤大鼠模型的影响,以寻找一种克服这些障碍的药物递送方法。

方法

通过动态光散射和透射电子显微镜鉴定纳米囊泡的特征。将 50 只雄性 Wistar 大鼠分为 5 组:假手术组;MI/R 组;MI/R+纳米囊泡组;MI/R+SIM 组;MI/R+SIM 载纳米囊泡组。结扎左前降支 45 分钟,在再灌注开始前 10 分钟,心肌内注射 3mg/kg SIM、纳米囊泡或 SIM 载纳米囊泡。ELISA 法检测心肌损伤标志物(cTnI、CK-MB)和炎症细胞因子(TNF-α、IL-6、TGF-β、MPC-1)。Western blot 法评价 MAPK-NF-κB 表达水平,苏木精-伊红染色法评价心肌组织病理学变化。

结果

纳米囊泡的粒径为 137nm,载 SIM 后达到 163nm。为了获得优化的纳米囊泡,Span80 为 80,药物/胆固醇的比例为 0.4,超声时间为 7 分钟。SIM 载纳米囊泡的包封率为 98.21%。与 MI/R+SIM 和 MI/R+SIM 载纳米囊泡相比,接受 SIM 载纳米囊泡的大鼠炎症细胞因子和 MAPK-NF-κB 表达水平降低。

结论

我们的结果表明,SIM 载纳米囊泡通过下调 MAPK-NF-κB 的激活,比 SIM 更有效地减轻再灌注损伤的急性炎症反应。

相似文献

1
Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury.辛伐他汀载纳米泡囊在心肌缺血再灌注损伤急性期有效下调 MAPK-NF-κB 通路。
Mol Biol Rep. 2022 Nov;49(11):10377-10385. doi: 10.1007/s11033-022-07891-3. Epub 2022 Sep 12.
2
Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury.载有辛伐他汀的纳米非离子表面活性剂囊泡对心肌缺血/再灌注损伤具有心脏保护作用。
Drug Deliv Transl Res. 2022 Jun;12(6):1423-1432. doi: 10.1007/s13346-021-01019-z. Epub 2021 Jun 24.
3
DNAzyme loaded nano-niosomes attenuate myocardial ischemia/reperfusion injury by targeting apoptosis, inflammation in a NF-κB dependent mechanism.载有 DNA 酶的纳米奈莫体通过靶向细胞凋亡、炎症反应NF-κB 依赖机制减轻心肌缺血/再灌注损伤。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):2127-2136. doi: 10.1007/s00210-023-02467-9. Epub 2023 Mar 21.
4
Simvastatin relieves myocardial ischemia/reperfusion injury in rats through hedgehog signaling pathway.辛伐他汀通过 hedgehog 信号通路缓解大鼠心肌缺血/再灌注损伤。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(11):6400-6408. doi: 10.26355/eurrev_202006_21538.
5
Protective effects of 4-methylumbelliferone on myocardial ischemia/reperfusion injury in rats through inhibition of oxidative stress and downregulation of TLR4/NF-κB/NLRP3 signaling pathway.4-甲基伞形酮对大鼠心肌缺血/再灌注损伤的保护作用通过抑制氧化应激和下调 TLR4/NF-κB/NLRP3 信号通路。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5015-5027. doi: 10.1007/s00210-023-02934-3. Epub 2024 Jan 6.
6
Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response.镁 lithospermate B 通过调节炎症反应减轻大鼠心肌缺血/再灌注损伤。
Pharm Biol. 2013 Nov;51(11):1355-62. doi: 10.3109/13880209.2013.791324. Epub 2013 Jul 18.
7
Retraction Note: Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury.撤稿说明:载辛伐他汀的纳米非离子表面活性剂囊泡在心肌缺血再灌注损伤急性期有效下调丝裂原活化蛋白激酶-核因子κB通路。
Mol Biol Rep. 2023 Jun;50(6):5533. doi: 10.1007/s11033-023-08436-y.
8
Propofol alleviates intestinal ischemia/reperfusion injury in rats through p38 MAPK/NF-κB signaling pathway.丙泊酚通过 p38MAPK/NF-κB 信号通路减轻大鼠肠缺血/再灌注损伤。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1574-1581. doi: 10.26355/eurrev_202102_24867.
9
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.IRFI 042,一种新型的类维生素E双重抗氧化剂,可抑制核因子-κB的激活并减轻心肌缺血再灌注损伤中的炎症反应。
Cardiovasc Res. 2000 Aug 18;47(3):515-28. doi: 10.1016/s0008-6363(00)00124-3.
10
[Effects and potential mechanisms of short-term use of simvastatin on myocardial no-reflow after ischemia-reperfusion in rats].[辛伐他汀短期应用对大鼠缺血再灌注后心肌无复流的影响及潜在机制]
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Aug;36(8):729-34.

引用本文的文献

1
PPARγ Regulates Macrophage Polarization by Inhibiting the JAK/STAT Pathway and Attenuates Myocardial Ischemia/Reperfusion Injury In Vivo.过氧化物酶体增殖物激活受体 γ 通过抑制 JAK/STAT 通路调节巨噬细胞极化,减轻体内心肌缺血/再灌注损伤。
Cell Biochem Biophys. 2023 Jun;81(2):349-358. doi: 10.1007/s12013-023-01137-0. Epub 2023 May 2.

本文引用的文献

1
Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review).心肌缺血/再灌注损伤:损伤机制及其对治疗的意义(综述)
Exp Ther Med. 2022 Jun;23(6):430. doi: 10.3892/etm.2022.11357. Epub 2022 May 6.
2
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting.针对缺血再灌注缓解中的 Nrf2:从信号网络到治疗靶点。
Life Sci. 2022 Jul 1;300:120561. doi: 10.1016/j.lfs.2022.120561. Epub 2022 Apr 20.
3
Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.
抑制心肌细胞凋亡是人参皂苷减轻心肌缺血/再灌注损伤的重要机制。
Front Pharmacol. 2022 Mar 1;13:806216. doi: 10.3389/fphar.2022.806216. eCollection 2022.
4
Molecular-Signaling Pathways of Ginsenosides Rb in Myocardial Ischemia-Reperfusion Injury: A Mini Review.人参皂苷 Rb 在心肌缺血再灌注损伤中的分子信号通路:小型综述。
Int J Med Sci. 2022 Jan 1;19(1):65-73. doi: 10.7150/ijms.64984. eCollection 2022.
5
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年缺血性心脏病负担及其可归因危险因素。
Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213.
6
Cardiomyocytes Cellular Phenotypes After Myocardial Infarction.心肌梗死后的心肌细胞表型
Front Cardiovasc Med. 2021 Nov 8;8:750510. doi: 10.3389/fcvm.2021.750510. eCollection 2021.
7
Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury.载有辛伐他汀的纳米非离子表面活性剂囊泡对心肌缺血/再灌注损伤具有心脏保护作用。
Drug Deliv Transl Res. 2022 Jun;12(6):1423-1432. doi: 10.1007/s13346-021-01019-z. Epub 2021 Jun 24.
8
Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model.自噬和 RhoA/ROCK 通路:Nesfatin-1 在心肌缺血/再灌注损伤大鼠模型中心脏保护作用的分子靶点。
Mol Biol Rep. 2021 Mar;48(3):2507-2518. doi: 10.1007/s11033-021-06289-x. Epub 2021 Mar 23.
9
Necrostatin-1 Analog DIMO Exerts Cardioprotective Effect against Ischemia Reperfusion Injury by Suppressing Necroptosis via Autophagic Pathway in Rats.Necrostatin-1 类似物 DIMO 通过抑制自噬通路抑制大鼠缺血再灌注损伤中的坏死性凋亡发挥心脏保护作用。
Pharmacology. 2021;106(3-4):189-201. doi: 10.1159/000510864. Epub 2021 Feb 23.
10
FoxO1 and Wnt/β-catenin signaling pathway: Molecular targets of human amniotic mesenchymal stem cells-derived conditioned medium (hAMSC-CM) in protection against cerebral ischemia/reperfusion injury.FoxO1 和 Wnt/β-catenin 信号通路:人羊膜间充质干细胞条件培养基(hAMSC-CM)在防治脑缺血再灌注损伤中的分子靶点。
J Chem Neuroanat. 2021 Mar;112:101918. doi: 10.1016/j.jchemneu.2021.101918. Epub 2021 Jan 6.